Skip to content

Role of herbal formulation in the management of melasma

Clinical study to evaluate the efficacy of varnya yoga (manjishtha-yashtimadhu-sariva)in the management of vyanga(melasma) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073631
Enrollment
60
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L814- Other melanin hyperpigmentation

Interventions

None listed

Sponsors

Institute of Post Graduate Ayurvedic Education And Reasearch at SVSP hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Clinical features like From ayurvedic text Neeruja(painless)Tanu(thin) Shyava Varna Yuktamandala (blue patches) on Mukhapradesh Hyperpigmented macules on face as per modern text. Patient are not under other medicine for melasma. patients willing for trial

Exclusion criteria

Exclusion criteria: Blackish and Reddish brown spot present all over the body exists since birth Any hyperpigmented patches due to leprosy will be excluded Hyper pigment caused by tumour like malignant melanoma. Hyperpigmented spot due to some endocrine and metabolic disorder like Addisons disease, Nelsons disease, Haemochromatosis, Pellagra Acne vulgaris,Inflammatory pigmentation Pregnant women, Lactating mother

Design outcomes

Primary

MeasureTime frame
oral use of varnya yoga may show better result in the symptoms like kandu, rukshata, daha, hyperpigmentation and reduction in size and number of patchesTimepoint: 45 Days

Secondary

MeasureTime frame
external use of varnya yoga may show better result in the symptoms like kandu, rukshata, daha, hyperpigmentation & reduction in size & number of patchesTimepoint: 45 days

Countries

India

Contacts

Public ContactRijuana sultana

The West Bengal University of Health Sciences, Kolkata

subirkrkhan2018@gmail.com8944006115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026